Literature DB >> 28783995

Therapeutic hypothermia in infants with hypoxic-ischemic encephalopathy and reversible persistent pulmonary hypertension: short-term hospital outcomes.

Sook Kyung Yum1, Yu Mi Seo1, Yoojin Kwun1, Cheong-Jun Moon1, Young-Ah Youn1, In Kyung Sung1.   

Abstract

AIM: Neonatal hypoxic ischemic encephalopathy (HIE) patients are at times accompanied by persistent pulmonary hypertension (PPHN), which is by itself another risk factor of adverse outcomes. We aimed to assess the outcome of therapeutic hypothermia (TH) in these patients whom we managed to reverse the shunt flow, as they are expected to be at much higher risk of adverse neurodevelopmental outcome.
METHODS: We reviewed the medical records of 116 HIE infants (13 with PPHN and 103 without PPHN) who underwent TH between 2012 and 2016. We analyzed the short-term hospital outcomes and brain study results (electroencephalogram and magnetic resonance imaging) of TH in these patients.
RESULTS: While infants with PPHN were significantly more likely to be outborn or have meconium aspiration syndrome, and required a longer duration of inotrope and intensive care support, electroencephalographic and brain magnetic resonance findings did not significantly differ according to PPHN status.
CONCLUSION: Based on our study, the hospital outcomes of infants with HIE accompanied by reversible PPHN who underwent TH were in general not significantly graver than those not accompanied by PPHN. Our results suggest that undergoing TH may be more beneficial in HIE infants with PPHN and the risks for possible adverse effects may not be as so high.

Entities:  

Keywords:  Hypoxic–ischemic encephalopathy; neurodevelopment; nitric oxide; persistent pulmonary hypertension; therapeutic hypothermia

Mesh:

Year:  2017        PMID: 28783995     DOI: 10.1080/14767058.2017.1365123

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  3 in total

1.  Pulmonary Hypertension Associated with Hypoxic-Ischemic Encephalopathy-Antecedent Characteristics and Comorbidities.

Authors:  Satyan Lakshminrusimha; Seetha Shankaran; Abbot Laptook; Scott McDonald; Martin Keszler; Krisa Van Meurs; Ronnie Guillet; Sanjay Chawla; Beena G Sood; Sonia Bonifacio; Abhik Das; Rosemary D Higgins
Journal:  J Pediatr       Date:  2018-03-01       Impact factor: 4.406

2.  MicroRNA-204 may participate in the pathogenesis of hypoxic-ischemic encephalopathy through targeting KLLN.

Authors:  Ronglin Chen; Meixia Wang; Shaopin Fu; Feng Cao; Pengkai Duan; Jiefu Lu
Journal:  Exp Ther Med       Date:  2019-08-26       Impact factor: 2.447

Review 3.  Emerging Trends in the Use of Therapeutic Hypothermia as a Method for Neuroprotection in Brain Damage (Review).

Authors:  E Sh Usmanov; M A Chubarova; Sh Kh Saidov
Journal:  Sovrem Tekhnologii Med       Date:  2020-10-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.